"A new vision for keratoconus: Epioxa redefines treatment after a decade-long wait" was originally created and published by ...

Two surgical procedures have been described for ICRS implantation: the mechanical method and the femtolaser method. The use of femtolaser for ICRS tunnel creation was widely accepted after FDA ...

The complications: Complications associated with keratoconus are corneal scarring, where scars form on the cornea, corneal ...

On Monday, Glaukos Corporation (NYSE:GKOS) received the “Day 74” notification from the U.S. Food and Drug Administration (FDA) acknowledging the previously submitted New Drug Application (NDA) for ...

Discover facts about keratoconus, its progression, treatment options, and ways to manage symptoms effectively for improved ...

SALT LAKE CITY--(BUSINESS WIRE)--iVeena Delivery Systems Inc. (“iVeena”), a clinical stage biopharmaceutical company with developmental products in keratoconus and pediatric myopia, has entered into a ...

The US Food and Drug Administration (FDA) has approved Glaukos Corporation’s Epioxa, offering patients living with a rare corneal disease a treatment option that does not require incisions.

Please provide your email address to receive an email when new articles are posted on . At Bascom Palmer Eye Institute, we are fortunate to have a large network of clinicians who refer patients to our ...

K: Keratometry; SE: Spheric equivalent. Intracorneal ring segments of smaller size and greater thickness provide a more corrective effect. Intracorneal ring segment (ICRS) implantation can be ...